Literature DB >> 19262431

Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

Hamid Hosseini, Mohammad Reza Khalili, Sarah Nowroozizadeh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19262431     DOI： 10.1097/IAE.0b013e31819a98a9

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.

Authors:  Joo Yong Lee; Ju Byung Chae; Sung Jae Yang; Young Hee Yoon; June-Gone Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09       Impact factor: 3.117

2.  Bevacizumab treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.

Authors:  Fei Feng; Yan Cheng; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

3.  Refractive status of Chinese with laser-treated retinopathy of prematurity.

Authors:  Lu Ruan; Hai-Dong Shan; Xing-Zong Liu; Xin Huang
Journal:  Optom Vis Sci       Date:  2015-04       Impact factor: 1.973

4.  Effect of ranibizumab on retinopathy of prematurity: A meta-analysis.

Authors:  Zhibin Wang; Zhaobo Zhang; Yue Wang; Yu Di
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

5.  Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity.

Authors:  Odalis Arámbulo; Gabriel Dib; Juan Iturralde; Fahir Duran; Miguel Brito; João B Fortes Filho
Journal:  Clin Ophthalmol       Date:  2015-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.